Cargando…
A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia
Patients with Severe Limb Ischemia (SLI) have a high risk of amputation and mortality. Here, we investigated a panel of serum biomarkers with the aim of identifying biomarkers for major events and mechanisms that contribute to disease progression in established SLI. A panel of biomarkers including G...
Autores principales: | Gremmels, Hendrik, Teraa, Martin, de Jager, Saskia C. A., Pasterkamp, Gerard, de Borst, Gert J., Verhaar, Marianne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656730/ https://www.ncbi.nlm.nih.gov/pubmed/31341203 http://dx.doi.org/10.1038/s41598-019-47217-1 |
Ejemplares similares
-
Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease
por: De Haan, Judith J., et al.
Publicado: (2017) -
Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective
por: Gremmels, Hendrik, et al.
Publicado: (2013) -
Cell Therapy for Chronic Limb‐Threatening Ischemia: Current Evidence and Future Directions
por: Teraa, Martin, et al.
Publicado: (2018) -
Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia
por: Wisman, Peter Paul, et al.
Publicado: (2015) -
Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment
of Chronic Limb-Threatening Ischemia
por: Leenstra, Bernard, et al.
Publicado: (2019)